Articles by George Koroneos, Online Content & News Editor - Pharmaceutical Executive

ADVERTISEMENT

Articles by George Koroneos, Online Content & News Editor

Novartis Bids Big on Alcon

Jan 6, 2010

It's just a few days into the new year and already a potential megamerger has been announced: Novartis offered $39 billion for complete control of ocular drug manufacturer Alcon.

Antidepressants Might Not Be A Sure Shot

Jan 6, 2010

A new JAMA study reveals that antidepressants might not have as strong an effect on people with less severe cases of depression. How this will affect the pharma industry, which once made heaps of cash with drugs like Prozac, remains to be seen.

Pharma Comes Under Fire for Jump in Rx Prices

Dec 9, 2009

Drug manufacturers came under fire at a hearing of the House Energy and Commerce?s health subcommittee for bumping drug prices 10 percent this year. Pharma claims rumors that it?s boosting costs in anticipation of healthcare reform are baseless, but the industry could be facing an uphill battle.

Layoffs and Job Cuts Brewing at Sanofi-Aventis

Dec 2, 2009

With the fourth quarter quickly coming to a close, talks of job cuts are once again in the air. The first major layoffs could be coming at Sanofi-Aventis, which is rumored to be slashing up to 1,500 positions.

A Call for Social Media Guidelines

Nov 18, 2009

Nearly 70 pharma execs, new media mavens, and even Joe Q. Public packed last week's FDA social media hearings to plead for some form of guidance on how to handle Tweets, blog comments, and off label discussions online.

Pfizer Quick on the Draw with R&D Location Plans

Nov 11, 2009

Following through with its promise to waste no time in merging Wyeth and Pfizer, the pharma giant announced restructuring plans for its global research network.

J&J Cuts Staff in Major Restructuring Move

Nov 4, 2009

Johnson & Johnson announced a massive restructuring plan on Tuesday in an effort to save $1.4 billion to $1.7 billion by 2011. The human cost: 7 percent of its workforce.

GAO Accuses FDA of Tardy Trial Data

Oct 28, 2009

The US oversight arm scripted a hefty report complaining that FDA is not moving fast enough when it comes to screening clinical trials data for drugs green lit through its expedited approval program.

Pfizer Profits Spike as Wyeth Deal is Finalized

Oct 21, 2009

The third quarter reports are in, and Pfizer's profits are up but sales are down. The company is compensating for looming patent expirations with layoffs and restructuring; is it enough to boost sales?

ADVERTISEMENT

Click here